Document Details

MGEN $9.02   $ (0.03) (0.33)%
Document Details

Filing Type

SC 13D (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Filing Date 2/24/2017


File Section(s)

  1. SCHEDULE 13D 2-24-17

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.